2004
DOI: 10.1038/nm1058
|View full text |Cite
|
Sign up to set email alerts
|

Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides

Abstract: We have previously shown that apolipoprotein E (Apoe) promotes the formation of amyloid in brain and that astrocyte-specific expression of APOE markedly affects the deposition of amyloid-beta peptides (Abeta) in a mouse model of Alzheimer disease. Given the capacity of astrocytes to degrade Abeta, we investigated the potential role of Apoe in this astrocyte-mediated degradation. In contrast to cultured adult wild-type mouse astrocytes, adult Apoe(-/-) astrocytes do not degrade Abeta present in Abeta plaque-bea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

22
382
0
1

Year Published

2005
2005
2020
2020

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 511 publications
(413 citation statements)
references
References 34 publications
22
382
0
1
Order By: Relevance
“…In the brain, ApoE plays a role in astrocyte‐mediated amyloid‐beta degradation (Koistinaho et al., 2004), supporting the amyloid cascade hypothesis of AD development (Hardy & Higgins, 1992). However, some researchers contend that variants of other genes in the APOE region play a role in AD development.…”
Section: Introductionsupporting
confidence: 61%
“…In the brain, ApoE plays a role in astrocyte‐mediated amyloid‐beta degradation (Koistinaho et al., 2004), supporting the amyloid cascade hypothesis of AD development (Hardy & Higgins, 1992). However, some researchers contend that variants of other genes in the APOE region play a role in AD development.…”
Section: Introductionsupporting
confidence: 61%
“…ApoE has been demonstrated to modulate Ah clearance and fibrillogenesis both in vitro (Beffert et al, 1999;Castano et al, 1995;Evans et al, 1994;Koistinaho et al, 2004;Ma et al, 1994;Yang et al, 1997Yang et al, , 1999 and in vivo (Bales et al, 1997;DeMattos et al, 2004;Holtzman et al, 2000;Shibata et al, 2000). In vivo, human apoE suppresses the onset of Ah deposition and subsequently results in an isoform-specific effect (E4 N E3 N E2) on the amount of Ah deposition, fibril formation, and neuritic plaque formation Holtzman et al, 2000).…”
Section: Discussionmentioning
confidence: 99%
“…Alternatively, apoE may modulate Ab removal from the brain to the systemic circulation by transport across the blood-brain barrier. Data from in vitro studies support the idea that apoE facilitates the binding and internalization of soluble Ab by cells or its clearance via enzymes such as neprilysn (Beffert et al 1998;Yang et al 1999;Cole and Ard 2000;Koistinaho et al 2004;Jiang et al 2008). Although in vitro studies suggest that apoE enhances cellular Ab uptake and degradation (Kim et al 2009a), there is in vivo evidence that apoE retards Ab clearance from the brain (DeMattos et al 2004;Bell et al 2007;Deane et al 2008), possibly via an effect at the blood -brain barrier (BBB) (Fig.…”
Section: Genetic Clinical and Biomarker Observations On Relationshimentioning
confidence: 95%
“…ApoE may also facilitate the cellular uptake of Ab through the endocytosis of a complex of apoE-containing lipoprotein particles bound to Ab in a manner that likely depends on the isoforms and its level of lipidation. Furthermore, apoE has been shown to directly enhance both the degradation of Ab within microglial cells and the ability of astrocytes to clear diffuse Ab deposits (Koistinaho et al 2004;Jiang et al 2008). Ab associated with apoEcontaining lipoprotein particles may also be retained within the CNS through their binding to heparin sulfate proteoglycan (HSPG) moieties present in the extracellular space (Mahley and Rall 2000).…”
Section: Genetic Clinical and Biomarker Observations On Relationshimentioning
confidence: 99%
See 1 more Smart Citation